Ectopic expression of BIRC5-targeting miR101-3p overcomes bone marrow stromamediated drug resistance in multiple myeloma cells

Multiple myeloma (MM) cells gain protection against drugs through interaction with bone marrow stromal cells (BMSCs). This form of resistance largely accounts for resistance to therapy in MM patients which warrants further exploration to identify more potential therapeutic targets.